SCHEDULE OF WARRANTS (Details) - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Accumulated Other Comprehensive Income (Loss) [Line Items]
Exchanged for common stock	(768,143)
Number of Shares, Outstanding at beginning	929,765	797,373
Weighted Average Exercise Price, Outstanding at beginning	$ 1.53	$ 1.99
Granted	124,100	378,800
Granted	$ 2.98	$ 0.94
Granted	(692,475)	(246,408)
Granted	$ 1.69	$ 1.94
Number of Shares, Outstanding at end	1,191,434	929,765	797,373
Weighted Average Exercise Price, Outstanding at end	$ 1.58	$ 1.53	$ 1.99
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term	5 years 3 months 18 days	6 years 1 month 6 days	5 years
Aggregate Intrinsic Value, Outstanding	$ 2,537,245
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number	958,915
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price	$ 1.50
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term	4 years 6 months
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value	$ 13,733
Warrant [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Warrant shares outstanding at beginning	3,730,805
Weighted average exercise Price, Outstanding at beginning	$ 2.05
Weighted Average Remaining Contractual Term (years) beginning	5 years 2 months 12 days	1 year 21 days
Intrinsic Value, Outstanding	$ 8,923,797
Warrant shares outstanding, Issued	4,146,146
Weighted average exercise price, Issued	$ 4.20
Warrant shares outstanding, Assumed pursuant to acquisition of Magic Med	5,913,672
Weighted average exercise price, Assumed pursuant to acquisition of Magic Med	$ 1.31
Warrant shares outstanding, Exercised	(3,253,714)
Weighted average exercise price, Exercised	$ 1.01
Warrant shares outstanding at end	9,768,766	3,730,805
Weighted average exercise price, Outstanding at end	$ 2.62	$ 2.05
[custom:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTermEnding]	3 years 4 months 24 days
Intrinsic Value, Exercisable	$ 801,024
Number of Shares, Outstanding at beginning	3,730,805	303,891
Weighted Average Exercise Price, Outstanding at beginning	$ 2.05	$ 1.99
Granted		3,701,730
Granted		$ 0.94
Granted		(274,816)
Granted		$ 1.94
Number of Shares, Outstanding at end		3,730,805	303,891
Weighted Average Exercise Price, Outstanding at end		$ 2.05	$ 1.99
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term		5 years 2 months 12 days
Aggregate Intrinsic Value, Outstanding	$ 8,923,797
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number		3,730,805
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price		$ 2.05
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term		5 years 2 months 12 days
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value		$ 8,923,797